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Abstract 
Intestinal type gastric adenocarcinoma is felt to develop over a protracted time period 
through a series of defined steps. Several potential risk factors for the development of 
gastric cancer have been identified, including a family history of gastric cancer and 
Helicobacter pylori infection. We present the case of a patient with neither risk factor who 
progressed in a 14 month time frame from histologically normal gastric mucosa to early 
stage intestinal type gastric adenocarcinoma in the setting of diffuse gastric intestinal 
metaplasia and atrophic gastritis. This patient’s presentation conflicts with our current 
understanding of the development of intestinal type gastric adenocarcinoma. 
Introduction 
The most common histologic variant of gastric adenocarcinoma is the intestinal 
type. One model for the development of intestinal type gastric cancer is a prolonged 
progression from atrophic gastritis to intestinal metaplasia (IM) followed by dysplasia 
and ultimately cancer [1].  
Helicobacter pylori (H. pylori) infection has been shown to be an important risk factor 
for the development of gastric adenocarcinoma [2–4]. Other potential risk factors for the 
development of gastric cancer include cigarette smoking, high salt intake, family history 
of gastric cancer, and pernicious anemia [5–8]. 
We present a patient who progressed in 14 months from histologically documented 
normal gastric mucosa to moderately differentiated intestinal type adenocarcinoma in the 
background of atrophic gastritis and IM.  
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Case Report 
The patient is a 74-year-old African-American female who initially presented in 2008 with 
odynophagia. Upper endoscopy performed at that time was unremarkable with the exception of a 
lipoma in the proximal stomach; mucosal biopsies from this area were unremarkable, including a 
Warthin-Starry stain for H. pylori. She then presented with oropharyngeal dysphagia approximately 
7 months later. The evaluation was notable for a cervical esophageal web on esophagram, which was 
confirmed during repeat upper endoscopy in July 2009. Esophageal dilation was performed at that time 
and the patient’s dysphagia initially improved; random biopsies obtained from the antrum of the 
stomach and esophagus were both normal. 
The patient reported recurrent dysphagia in September 2010 without overt gastrointestinal bleeding, 
early satiety, nausea, vomiting, or unintentional weight loss. Repeat upper endoscopy demonstrated a 
presumptive recurrent proximal esophageal web that was successfully dilated as well as a 1 cm nodular 
area with overlying friability and depressed center in the body of the stomach that was not present on 
prior upper endoscopies (fig. 1). Biopsies from this area demonstrated intramucosal carcinoma and IM 
without evidence of H. pylori infection. Subsequent random gastric biopsies throughout the stomach 
demonstrated diffuse IM. Radial array endoscopic ultrasound (EUS) (GF-UE160, Olympus America 
Incorporated, Center Valley, Pa.) examination was performed to assess the feasibility of endoscopic 
mucosal resection of the nodular area in the stomach. EUS demonstrated no enlarged perigastric lymph 
nodes or abnormalities in the visualized left lobe of the liver but invasion of the nodular lesion into the 
submucosa (fig. 2). 
Given the depth of invasion of the lesion by EUS, endoscopic mucosal resection was not performed 
and the patient was referred for surgery. Preoperative CT chest, abdomen, and pelvis as well as PET-CT 
did not demonstrate evidence of locally advanced or metastatic disease. The patient underwent subtotal 
gastrectomy with Roux-en-Y reconstruction without complications. The final pathology demonstrated 
pT1b, pN0, pMX intestinal type moderately differentiated adenocarcinoma in the setting of atrophic 
gastritis and extensive IM with no malignancy at the resection margins. 
The patient’s past medical history is notable for early stage squamous cell carcinoma of the left 
vocal cord that had been definitively treated with external beam radiation in 2002. She reported a 
40 pack-year cigarette smoking history and had quit smoking in 2002. Her family history is negative 
for gastric cancer and the patient was born and raised in the United States. 
Discussion 
It is generally believed that the development of intestinal type gastric cancer is a 
prolonged process starting with the development of atrophic gastritis followed by IM. 
While this patient does have potential risk factors for the development of gastric cancer, 
namely a history of cigarette smoking and being of African-American descent, the rapid 
progression in 14 months from normal gastric mucosa to atrophic gastritis, IM, and 
cancer is unusual and contradicts the paradigm noted above. Other risk factors for the 
development of gastric cancer such as H. pylori infection, family history of gastric cancer, 
and pernicious anemia were not present and the patient was not from an area with a high 
prevalence of gastric cancer. Presumably, other unrecognized risk factors contributed to 
this patient’s presentation. 
Gastric IM is a common entity that has been estimated to occur in up to 50% of 
patients in Western countries [9]. Some investigators have suggested that endoscopic 
surveillance may be beneficial in patients with atrophic gastritis or gastric IM [10, 11]. 
However, surveillance of all patients with gastric IM is controversial in Western countries 
given the low incidence of gastric cancer [12, 13]. Irrespective of this issue, endoscopic 
screening was not an option in this patient since the diagnosis of gastric IM was made at 
the same time as the diagnosis of gastric cancer.  
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This case is the first to our knowledge that documents the rapid development of 
intestinal type gastric adenocarcinoma in a patient with previously normal gastric 
mucosa, specifically without a precancerous lesion such as IM. Further studies to identify 
previously unknown risk factors for gastric cancer as well as to better define which 
patients with atrophic gastritis or gastric IM are at higher risk for developing dysplasia 
and cancer are needed. 
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Fig. 1. Endoscopic appearance of the nodular malignant lesion in the stomach. 
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Fig. 2. EUS of the stomach showing invasion of the malignant lesion into the submucosal layer. 
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